Mundipharma EDO GmbH

🇨🇭Switzerland

Active:0

Completed:0

1 Phases

Phase 1:1

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1

1 (100.0%)

Phase 1

Terminated

Conditions: Multiple Myeloma Progression
Multiple Myeloma With Failed Remission
Multiple Myeloma in Relapse

Interventions: Drug: Tinostamustine
Procedure: Autologous Stem Cell Transplant (ASCT)

Locations: 🇺🇸
University of Alabama, Birmingham, Alabama, United States
🇺🇸
University of Kansas Medical Center Kansas City, Kansas City, Kansas, United States
🇺🇸
Memorial Sloan Kettering Cancer Centre, New York, New York, United States

No news found